O. Orbay Et Al. , "Comparison of neoadjuvant systemic treatment (chemotherapy with or without trastuzumab) responses with dynamic contrast-enhanced breast magnetic resonance imaging and histopathology in locally advanced breast cancer," 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) , vol.30, Illinois, United States Of America, 2012
Orbay, O. Et Al. 2012. Comparison of neoadjuvant systemic treatment (chemotherapy with or without trastuzumab) responses with dynamic contrast-enhanced breast magnetic resonance imaging and histopathology in locally advanced breast cancer. 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) , (Illinois, United States Of America).
Orbay, O., Demirkan, H. M. B., Balci, P., GÜRAY DURAK, M., & Saydam, S., (2012). Comparison of neoadjuvant systemic treatment (chemotherapy with or without trastuzumab) responses with dynamic contrast-enhanced breast magnetic resonance imaging and histopathology in locally advanced breast cancer . 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, United States Of America
Orbay, Ozge Et Al. "Comparison of neoadjuvant systemic treatment (chemotherapy with or without trastuzumab) responses with dynamic contrast-enhanced breast magnetic resonance imaging and histopathology in locally advanced breast cancer," 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, United States Of America, 2012
Orbay, Ozge Et Al. "Comparison of neoadjuvant systemic treatment (chemotherapy with or without trastuzumab) responses with dynamic contrast-enhanced breast magnetic resonance imaging and histopathology in locally advanced breast cancer." 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) , Illinois, United States Of America, 2012
Orbay, O. Et Al. (2012) . "Comparison of neoadjuvant systemic treatment (chemotherapy with or without trastuzumab) responses with dynamic contrast-enhanced breast magnetic resonance imaging and histopathology in locally advanced breast cancer." 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) , Illinois, United States Of America.
@conferencepaper{conferencepaper, author={Ozge Orbay Et Al. }, title={Comparison of neoadjuvant systemic treatment (chemotherapy with or without trastuzumab) responses with dynamic contrast-enhanced breast magnetic resonance imaging and histopathology in locally advanced breast cancer}, congress name={48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)}, city={Illinois}, country={United States Of America}, year={2012}}